- Category
- Micro (2022-23)
- Udyam number
- UDYAM-WB-09-0009345

Celoris Pharmaceuticals Private Limited
About Celoris Pharmaceuticals Private Limited
Data last updated:
Celoris Pharmaceuticals Private Limited is a private limited company based in Jalpaiguri, West Bengal, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 27 July 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2022PTC255969.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹20,000. It is led by directors including Amit Sharma Kumar and Chandni Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gitanjali Appartment Ukilpara, Jalpaiguri, West Bengal, India – 735101.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.11 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹90,437 (net margin 0.8%) and EBITDA of ₹1.22 Lakh (EBITDA margin 1.1%).
As per MCA filings, the company has open charges of ₹6 Lakh on record.
Celoris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-09-0009345). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Celoris Pharmaceuticals
Contact details
Celoris Pharmaceuticals Private Limited's registered office is in Jalpaiguri, West Bengal.
- Registered AddressGitanjali Appartment Ukilpara, Jalpaiguri, West Bengal, India – 735101
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Celoris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Celoris Pharmaceuticals Private Limited, buy the company report.
Financials of Celoris Pharmaceuticals Private Limited
FY 2025 filings availableCeloris Pharmaceuticals Private Limited reported revenue of ₹1.11 Cr (up 279% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 279% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.22 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹90,437 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.1% | |
| Net Profit Margin | 0.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Celoris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Celoris Pharmaceuticals Private Limited
Celoris Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Sharma Kumar Also directs: Dasham Medicare Private Limited, Dishari Medicare Private Limited, Omkar Medi Services Private Limited and 1 more | Director | 01 Oct 2024 | 2 Years 0 Months | Current |
| Chandni Banerjee | Director | 27 Jul 2022 | 4 Years 3 Months | Current |
| Bijendra Kumar Gupta | Director | 27 Jul 2022 | 4 Years 3 Months | Current |
| Anil Kumar Sah Also directs: Terra Acres Agri Industries LLP | Director | 01 Oct 2024 | 2 Years 0 Months | Current |
Peer comparison
Celoris Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saudavel Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | -32.0% | Margao, Goa, India | |||
| Rydan Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | 24.0% | Jaipur, Rajasthan, India | |||
| Sreeha Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2021) | 752.0% | Hyderabad, Telangana, India | |||
| Celoris Pharmaceuticals Private Limitedthis company | ₹1.11 Cr (FY 2024) | ₹90,437 | 0.8% | 279.0% | Jalpaiguri, West Bengal, India |
To see the full peer comparison of Celoris Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jul 2024 | 100987696 | Others | ₹6 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Celoris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celoris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Celoris Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Celoris Pharmaceuticals Private Limited has 8 board changes on record since 2022: 4 appointments and 4 cessations. The latest: Bikrant Verma ceased to be Director on 31 Mar 2025.
Frequently asked questions
Celoris Pharmaceuticals is an active private limited company based in Jalpaiguri, West Bengal, India. The company works in specialty, within the trading industry. It was incorporated on 27 July 2022 (4+ years old) and is registered under CIN U51909WB2022PTC255969.
Celoris Pharmaceuticals has 4 current directors:
- Amit Sharma Kumar - Director
- Chandni Banerjee - Director
- Bijendra Kumar Gupta - Director
- Anil Kumar Sah - Director
The latest financial statements of Celoris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Celoris Pharmaceuticals is U51909WB2022PTC255969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celoris Pharmaceuticals was incorporated on 27 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Celoris Pharmaceuticals by revenue are Saudavel Pharmaceuticals Private Limited, Rydan Pharmaceuticals Private Limited, Sreeha Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bikrant Verma ceased to be Director on 31 Mar 2025. Rajib Kumar Jha ceased to be Director on 31 Mar 2025. Sumit Kumar Sharma ceased to be Director on 31 Mar 2025. Celoris Pharmaceuticals has 8 board changes on record in total.
Yes, Celoris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-09-0009345).
The registered office of Celoris Pharmaceuticals is at Gitanjali Appartment Ukilpara, Jalpaiguri, West Bengal, India – 735101.
Celoris Pharmaceuticals operates in the trading industry, in the specialty segment.
Celoris Pharmaceuticals has open charges of ₹6 Lakh and no satisfied charges on record as per latest MCA filings.